Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 81

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 81
---
 as practicable
(and in any event within 45 calendar days following the date of the Inducement Agreement), and to use commercially reasonable efforts
to have the Resale Registration Statement declared effective by the SEC and to keep such registration statement effective at all times
until the Holders no longer own any Inducement Warrants or Inducement Warrant Shares. We are filing this Resale Registration Statement
to fulfil our obligation to register the Inducement Warrant Shares and to also register the Advisor Warrant Shares.

Terms of the Inducement Warrants

The Inducement Warrants have an exercise price of
$0.85 per share, subject to adjustment as provided in the Inducement Warrants, will be exercisable at any time on or after the date
on which the Company receives stockholder approval of the exercisability of the Inducement Warrants and the issuance of the Inducement
Warrant Shares upon exercise thereof (the “Stockholder Approval Date”) and have a term of exercise of five (5) years from
the Stockholder Approval Date.

| 36 |

If at any time after the later of (i) the six-month anniversary of the Closing Date, and (ii) the Stockholder Approval Date, a registration statement registering the issuance of the Inducement Warrant Shares under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the Inducement Warrants through a cashless exercise, in which case the holder would receive upon such exercise the net number of shares of Common Stock determined according to the formula set forth in the Inducement Warrants.

The exercise price of the Inducement Warrants, and the number of Inducement Warrant Shares, are subject to adjustment in the event of any stock dividend or split, reverse stock split, recapitalization, reorganization or similar transaction, as described in the Inducement Warrants. The Company may also at any time during the term of the Inducement Warrants, subject to the prior written consent of the holder, voluntarily reduce the then current exercise price to any amount and for any period of time, subject to the rules and regulations of Nasdaq.

A holder will not have the right to exercise any portion of the Inducement Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or, upon election of the holder, 9.99%) of the number of shares